Sort
48,018 grants matching “immunotherapy”
Cancer Center Support Grant
$2,467,468Thomas P Loughran · University Of Virginia · P30 · FY2015 · CA
Tissue compartmentalization of human lymphocytes
$2,467,075Donna L Farber · Columbia University Health Sciences · P01 · FY2017 · AI
Defining regulators of immunity to acute infection using CRISPR screens
$2,462,939Arlene H Sharpe · Harvard Medical School · U19 · FY2017 · AI
Genes and signals controlling mammalian hematopoiesis.
$2,462,161Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Experimental Therapy for Brain Tumors
$2,461,078John H Sampson · Duke University · P01 · FY2019 · CA
Tissue compartmentalization of human lymphocytes
$2,459,854Donna L Farber · Columbia University Health Sciences · P01 · FY2021 · AI
CANCER CENTER SUPPORT GRANT
$2,459,346Gerold Bepler · Wayne State University · P30 · FY2014 · CA
DF/HCC Renal Cancer SPORE
$2,458,254Beth Israel Deaconess Medical Center · P50 · FY2005 · CA
Hematopoiesis in cardiovascular disease
$2,456,980Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2019 · HL
AIDS associated Toxoplasma encephalitis
$2,456,732Louis M. Weiss · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Synthetically Reengineered T cells as the Next Generation of Smart Cancer Therapy
$2,455,500Wilson Wong · Boston University (Charles River Campus) · DP2 · FY2013 · CA
SPORE in Soft Tissue Sarcoma
$2,453,831Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,453,778Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2022 · CA
Development of Novel Vaccine Strategies
$2,453,605Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,453,222Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,452,679Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2023 · CA
Convergent Epigenetic Control of Neuroendocrine Cancers
$2,452,400James A Decaprio · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Tissue compartmentalization of human lymphocytes
$2,452,058Donna L Farber · Columbia University Health Sciences · P01 · FY2022 · AI
Spore in Head and Neck Cancer
$2,451,382David Sidransky · Johns Hopkins University · P50 · FY2015 · DE
SPORE in Cervical Cancer
$2,450,204Johns Hopkins University · P50 · FY2004 · CA
Hematopoiesis in cardiovascular disease
$2,448,526Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2020 · HL
Targeted Therapies in Melanoma
$2,448,186Meenhard Herlyn · Wistar Institute · P01 · FY2022 · CA
DF/HCC Renal Cancer SPORE
$2,447,662Beth Israel Deaconess Medical Center · P50 · FY2004 · CA
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
$2,447,228Thomas M Wisniewski · New York University School Of Medicine · P01 · FY2021 · AG
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,447,225John M Maris · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA